Overview

Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese Male Subjects

Status:
Completed

Trial end date:
2007-10-01

Target enrollment:

Participant gender:

Summary

This study is being conducted to assess the safety and tolerability of ascending multiple oral doses of SCA-136 administered to healthy Japanese male subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Wyeth is now a wholly owned subsidiary of Pfizer